- Expires: December 28, 2022
- Credit: 1.00hr(s)
- CME
- Therapeutic Areas: Oncology, Urologic oncology
- Specialties: urothelial carcinoma (UC)
- On-Demand
Visualizing Progress for TP53 Mutant AML: A Pathology-Guided Journey through Diagnostic Principles and Modern Treatment
- Available: May 5, 2021 —
- May 4, 2022
- Credit: 0.50hr(s)
- Credit Types: ABIM, ABPath, CC, CME, MOC
- Therapeutic Areas: Oncology
- Specialties: AML
- Location: Internet Activity Enduring
Course Description
In this activity, an expert pathologist discusses the prognostic relevance of TP53 mutations, current diagnostic tools and principles for capturing TP53-mutated acute myeloid leukemia (AML), and new developments with innovative therapy for TP53-mutated AML.
Other Courses in this Series
Other Courses That May be of Interest
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC